These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786 [TBL] [Abstract][Full Text] [Related]
29. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response. Meijer TW; Hoogerbrugge N; Nagengast FM; Ligtenberg MJ; van Krieken JH Histopathology; 2009 Oct; 55(4):414-22. PubMed ID: 19817892 [TBL] [Abstract][Full Text] [Related]
30. Novel approaches in evaluation of pathogenicity of single-base exonic germline changes involving the mismatch repair genes MLH1 and MSH2 in diagnostics of Lynch syndrome. Gerykova-Bujalkova M; Krivulcik T; Bartosova Z Neoplasma; 2008; 55(6):463-71. PubMed ID: 18999873 [TBL] [Abstract][Full Text] [Related]
31. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Walsh MD; Cummings MC; Buchanan DD; Dambacher WM; Arnold S; McKeone D; Byrnes R; Barker MA; Leggett BA; Gattas M; Jass JR; Spurdle AB; Young J; Obermair A Clin Cancer Res; 2008 Mar; 14(6):1692-700. PubMed ID: 18310315 [TBL] [Abstract][Full Text] [Related]
32. The hMSH2 and hMLH1 genes in hereditary nonpolyposis colorectal cancer. Lynch PM Surg Oncol Clin N Am; 2009 Oct; 18(4):611-24. PubMed ID: 19793569 [TBL] [Abstract][Full Text] [Related]
33. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC. Morak M; Schackert HK; Rahner N; Betz B; Ebert M; Walldorf C; Royer-Pokora B; Schulmann K; von Knebel-Doeberitz M; Dietmaier W; Keller G; Kerker B; Leitner G; Holinski-Feder E Eur J Hum Genet; 2008 Jul; 16(7):804-11. PubMed ID: 18301449 [TBL] [Abstract][Full Text] [Related]
34. Letter in response to "Identifying Lynch syndrome" by de la Chapelle et al. Jenkins MA; Dowty JG; Hopper JL; Tucker K; Southey MC Int J Cancer; 2010 Jun; 126(11):2757-8. PubMed ID: 19847809 [No Abstract] [Full Text] [Related]
35. [Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer]. Wullen B; Mühlhöfer A; Zoller WG Z Gastroenterol; 2001 Nov; 39(11):981-4. PubMed ID: 11778159 [No Abstract] [Full Text] [Related]
37. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation]. Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244 [TBL] [Abstract][Full Text] [Related]
38. Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment. Jensen LH; Dysager L; Lindebjerg J; Kølvrå S; Byriel L; Crüger DG Eur J Cancer; 2010 Jul; 46(10):1823-8. PubMed ID: 20417091 [TBL] [Abstract][Full Text] [Related]
39. Genetic testing for hereditary nonpolyposis colorectal cancer. Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209 [TBL] [Abstract][Full Text] [Related]
40. High frequency of large gene deletions and rearrangements in Lynch syndrome--back to the future? Eng C Gastroenterology; 2005 Sep; 129(3):1124-6. PubMed ID: 16143150 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]